DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

CT Homepage

Berlin institute sets world record for fastest 3D tomographic images Produces an image every 40 milliseconds with more affordable system

Richardson Healthcare obtains ISO 13485:2016 certification Strengthens its status as a CT and power grid tube manufacturer

New brands, proven experts lead a new era in the CT tube market The CT market has changed a lot over the last couple years

MaxQ-AI seeks $8 million public IPO listing on Nasdaq Will help FDA regulatory processes for Accipio software products

Is a CT tube crisis on the horizon? As more scanners enter the market, will tubes be sufficiently available?

Siemens and NuVasive collab to enhance spinal surgery Combines NuVasive's Pulse system with Siemens Cios Spin

NIH grants $1.5 million to Magnetic Insight for development of new imaging modality Uses non-radioactive, iron oxide nanoparticle tracer

China hits back with new tariffs affecting medical imaging equipment More than 5,000 items affected, including X-ray tubes and gamma-ray equipment

Bracco Imaging and Duke form CT R&D collaboration Developing software to improve contrast CT administration

Elizabeth Krcik, Denise Yost and Liberty Adair ARRT honors three in I Am the Gold Standard program

3-D map of the PSMA-positive
lesions (yellow)

Study finds PSMA PET/CT can identify early prostate cancer recurrence

Lauren Dubinsky , Senior Reporter
Gallium-68 prostate-specific membrane antigen PET/CT imaging can spot early prostate cancer recurrence after radical prostatectomy, according to a new study published in The Journal of Nuclear Medicine.

“Currently there is no sensitive standard imaging method for spotting prostate cancer early recurrence,” Dr. Jeremie Calais of UCLA, told HCB News. “PSA is an indirect tool that reflects the burden of active prostate cancer disease in the whole body, but it cannot localize it.”

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



A decade after radical prostatectomy, 20 to 80 percent of patients experience prostate cancer biochemical recurrence. Salvage radiotherapy is the standard treatment option, but bone scan, CT, MR, bone PET/CT, choline PET/CT and Fluciclovine PET/CT exams are not sensitive enough to pinpoint the location of recurrence.

For the study, Calais and his team evaluated 270 patients with biochemical recurrence of prostate cancer after radical prostatectomy who were not previously treated with radiotherapy. They had each patient undergo PSMA PET/CT exams.

Almost half of the patients had a positive PSMA PET/CT and 52 had at least one PSMA-positive lesion that was not covered by the consensus clinical target volume. The team concluded that PSMA PET/CT would have a potentially significant impact on the outcomes of salvage radiotherapy for about 20 percent of the patients.

Although PSMA PET/CT is the standard of care for prostate cancer recurrence in many countries, it has not yet been approved for use in the U.S.

“Once approved and reimbursed we strongly believe that it will be rapidly implemented as standard routine care of prostate cancer patients and widely used,” said Calais.

CT Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有